Navigate challenges with strategic …

• Revenue: USD 777.9 million, decline of 1.8% compared to the previous year.

• Adapted EBITDA: $ 127.9 million, 19.3% compared to the previous year.

• Fitted EBITDA margins: 16.4%.

• Free Cashflow: Negative USD 0.1 million improves from a negative $ 38.9 million compared to the previous year.

• Reduction in debt: Reduced debts by $ 25 million in the first quarter of 2025.

• Nettos: 1.96 billion US dollars with a net compatibility of 2.98x.

• Income from the breathing health segment: USD 165.5 million, increased by 3.3%compared to the previous year.

• Income from the diabetes health segment: 138.8 million USD, decreased by 8.0% compared to the previous year.

• Income from the bed health segment: USD 316.4 million, decline of 2.8% compared to the previous year.

• Cashflow from the company: 95.5 million US dollars.

• Investment: USD 95.6 million, 12.3% of sales.

• Unreserved money: 53.7 million US dollars at the end of the quarter.

• Instructions for 2025: Sales of 3.18 billion US dollars up to 3.32 billion US dollars; Adjusted EBITDA from USD 665 million to $ 705 million.

Appearance date: May 06, 2025

You can find the complete copy of the earnings call in the complete earnings call.

• Turnover with the first quarter exceeded the center of the guidelines by $ 13.1 million, which is due to a strong performance in health segments for the health and diabetes of the airways.

• The diabetes health segment showed signs of relaxation with sequential improvement in restarting and the best replenishment rate for two years.

• Adapthealth Corp (NASDAQ: AHCO) reduced its $ 25 million $ 25 million in the first quarter and contributed to a total repayment of $ 195 million in the last five quarters.

• The company is on the right track to achieve its free cash flow guidelines for the whole year, with a significant improvement in negative $ 38.9 million to a negative $ 0.1 million in the previous year.

• The adapthealth corp (Nasdaq: AHCO) has a wide geographical footprint with over 660 locations, which positions it well to record market shares and to guide the transformation of the home health industry.

• The adjusted EBITDA in the first quarter decreased by 19.3% compared to the same year last year, and adjusted EBITDA margin fell from 20.0% to 16.4%.

• The net turnover for the first quarter decreased by 1.8% compared to the previous year, which was partly due to a business day.

• The Sleep Health segment placed expectations below average, whereby net sales were slightly due to expectations by 2.8% and new setups.

• The Free Cashflow was negative and certain cash collections in the first quarter were anticipated in the second quarter.

• The company reduced its sales expectations of $ 40 million in the year and adjusted the EBITDA expectations of $ 5 million due to the assessment of certain incontinence.